Full Length Research Paper
References
|
Ambler RP (1980). The structure of β-lactamases. Philosophical Transactions of the Royal Society B: Biological 289(1036):321-331. |
|
|
Briñas L, Zarazaga M, Sáenz Y, Ruíz-Larrea F, Torres C (2002). B-lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans and Healthy Animals. Antimicrobial Agents and Chemotherapy 46(10):3156-3163. |
|
|
Bush K, Jacoby GA (2010). Updated functional classification of β-lactamases. Antimicrobial Agents and Chemotherapy 54(3):969-976. |
|
|
Caroff N, Espaze E, Bérard I, Richet H, Reynaud A (1999). Mutations in the ampC promoter of Escherichia coli isolates resistant of oxyimino cephalosporins without extended-spectrum beta-lactamase production. FEMS Microbiology Letters 173(2):459-465. |
|
|
Caroff N, Espaze E, Gautreau D, Richet H, Reynaud A (2000). Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. Journal of Antimicrobial Chemotherapy 45:783-788. |
|
|
Caspermeyer J (2016). Mega Evolutionary Software re-engineered to Handle Today's Big Data Demands. Molecular Biology and Evolution 33(7):1887. |
|
|
CLSI (2017). Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standard Institute: 2017. |
|
|
Corvec S, Caroff N, Espaze E, Marraillac J, Reynaud A (2002). -11 Mutation in the ampC Promoter Increasing Resistance to β-Lactams in a Clinical Escherichia coli Strain. Antimicrobial Agents and Chemotherapy 46(10):3265-3267. |
|
|
den Drijver E, Verweij JJ, Verhulst C, Oome S, Soer J, Willemsen I, Schrauwen EJA, Kluytmans-van den Bergh MFQ, Kluytmans JAJW (2018). The decline in AmpC β-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016). PLoS One 13(10):e0204864. |
|
|
Hiroi M, Harada T, Kawamori F, Takahashi N, Kanda T, Sugiyama K, Masuda T, Yoshikawa Y, Ohashi N (2011). A survey of b-lactamase-producing Escherichia coli in farm animals and raw retail meat in Shizuoka Prefecture, Japan. Japanese Journal of Infectious Diseases 64:153-155. |
|
|
Haenni M, Châtre P, Madec J (2014). Emergence of Escherichia coli producing extended-spectrum AmpC β-lactamases (ESAC) in animals. Front Microbiology 5:53. |
|
|
Johnson JW, Fisher JF, Mobashery S (2013). Bacterial cell-wall recycling. Annals of New York Academy of Science 1277(1):54-75. |
|
|
Jorgensen RL, Nielsen JB, Friis-Moller A, Fjeldsoe-Nielsen H, Schonning K (2010). Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype. Antimicrobial Chemotherapy 65:460-464. |
|
|
Kohlmann R, Bähr T, Gatermann SG (2018). Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase. Journal of Antimicrobial Chemotherapy 73(6):1530-1536. |
|
|
Kojima A, Yoshikazu I, Kanako I, Esaki H, Asai T, Oda C, Tamura Y, Takahashi T, Yamaguchi K (2005). Extended-Spectrum--Lactamase-Producing Escherichia coli Strains Isolated from Farm Animals from 1999 to 2002: Report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program. Antimicrobial Agents and Chemotherapy 49(8):3533-3537. |
|
|
Koneman EW, Allen SD, Janda WM, Schreckenbergere PC, Winn WC (2010). Microbiologic Diagnostic. MEDS, Rio de Janeiro, RJ. |
|
|
Mammeri H, Poirel L, Fortineau N, Nordmann P (2006). Naturally Occurring Extended-Spectrum Cephalosporinases in Escherichia coli. Antimicrobial Agents and Chemotherapy 50(7):2573-2576. |
|
|
Olesen I, Hasman H, Aareestrup FM (2004). Prevalence of b-lactamases among Ampicillin-Resistant Escherichia coli and Salmonella isolated from food animals in Denmark. Microbial Drug Resistance 10(4):334-340. |
|
|
Olsson O, Bergstrom S, Lindberg FP, Normark S (1983). AmpC β-lactamase hyperproduction in Escherichia coli: Natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella. Proceedings of the National Academy of Science USA 80:7556-7560. |
|
|
Rodrigues NMB, Bronzato GF, Santiago GS, Botelho LAB, Moreira BM, Coelho IS, Souza MMS, Coelho SMO (2017). The matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) identification versus biochemical tests: A study with enterobacteria from a dairy cattle environment. Brazilian Journal of Microbiology 48:132-138. |
|
|
Rodríguez-Martínez JM, Fernández-Echauri P, Fernández-Cuenca F, Alba PD, Briales, A, Pascual A (2012). Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolyzing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aero genes selected in vivo. Journal of Antimicrobial Chemotherapy 67(1):64-68. |
|
|
Santiago GS, Motta CC, Bronzato GF, Gonçalves D, Souza MMS, Coelho IS, Ferreira HN, Coelho SMO (2016). Revisão: Produção de β-lactamases do Tipo AmpC em Enterobacteriaceae. Revista Brasileira Medicina Veterinária 38(Supl.3):17-30. |
|
|
Santiago GS (2017). Compreensão de mecanismos fenotípicos e genotípicos relacionados à produção de β-lactamases do tipo AmpC em Enterobacteriaceae. MS Thesis. Federal Rural University of Rio de Janeiro, RJ, Brazil. 2017. |
|
|
Siu LK, Lu PL, Chen JY, Lin FM, Chang SC (2003). High-Level Expression of AmpC b-Lactamase Due to Insertion of Nucleotides between _10 and _35 Promoter Sequences in Escherichia coli Clinical Isolates: Cases Not Responsive to Extended-Spectrum-Cephalosporin Treatment. Antimicrobial Agents and Chemotherapy 47(7):2138-2144. |
|
|
Yu W, Bing L, Zhenhua L (2009). ampC promoter and attenuator mutations affect function of three Escherichia coli strains. Current Microbiology 59(3):244-247. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
